Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

Lokinendi V. Rao, Olapade A. James, Linda M. Mann, Amin A. Mohammad, Anthony Okorodudu, Michael G. Bissell, John R. Petersen

Research output: Contribution to journal › Article

2 Citations (Scopus)

Abstract

We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

Original languageEnglish (US)
Pages (from-to)13-15
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume27
Issue number1-2
DOIs
StatePublished - Jan 1997

Fingerprint

Congenital Toxoplasmosis
Toxoplasma
Prenatal Diagnosis
Immunoglobulin G
Charadriiformes
Fluorescence

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Virology
  • Parasitology
  • Microbiology
  • Immunology
  • Applied Microbiology and Biotechnology

Cite this

Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis. / Rao, Lokinendi V.; James, Olapade A.; Mann, Linda M.; Mohammad, Amin A.; Okorodudu, Anthony; Bissell, Michael G.; Petersen, John R.

In: Diagnostic Microbiology and Infectious Disease, Vol. 27, No. 1-2, 01.1997, p. 13-15.

Research output: Contribution to journal › Article

Rao, LV, James, OA, Mann, LM, Mohammad, AA, Okorodudu, A, Bissell, MG & Petersen, JR 1997, 'Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis', Diagnostic Microbiology and Infectious Disease, vol. 27, no. 1-2, pp. 13-15. https://doi.org/10.1016/S0732-8893(96)00215-5
Rao LV, James OA, Mann LM, Mohammad AA, Okorodudu A, Bissell MG et al. Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis. Diagnostic Microbiology and Infectious Disease. 1997 Jan;27(1-2):13-15. https://doi.org/10.1016/S0732-8893(96)00215-5
Rao, Lokinendi V. ; James, Olapade A. ; Mann, Linda M. ; Mohammad, Amin A. ; Okorodudu, Anthony ; Bissell, Michael G. ; Petersen, John R. / Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis. In: Diagnostic Microbiology and Infectious Disease. 1997 ; Vol. 27, No. 1-2. pp. 13-15.
@article{065494527e7541d4bea145a2001b0d65,
title = "Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis",
abstract = "We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.",
author = "Rao, {Lokinendi V.} and James, {Olapade A.} and Mann, {Linda M.} and Mohammad, {Amin A.} and Anthony Okorodudu and Bissell, {Michael G.} and Petersen, {John R.}",
year = "1997",
month = "1",
doi = "10.1016/S0732-8893(96)00215-5",
language = "English (US)",
volume = "27",
pages = "13--15",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "1-2",

}

TY - JOUR

T1 - Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

AU - Rao, Lokinendi V.

AU - James, Olapade A.

AU - Mann, Linda M.

AU - Mohammad, Amin A.

AU - Okorodudu, Anthony

AU - Bissell, Michael G.

AU - Petersen, John R.

PY - 1997/1

Y1 - 1997/1

N2 - We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

AB - We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

UR - http://www.scopus.com/inward/record.url?scp=0030891252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030891252&partnerID=8YFLogxK

U2 - 10.1016/S0732-8893(96)00215-5

DO - 10.1016/S0732-8893(96)00215-5

M3 - Article

VL - 27

SP - 13

EP - 15

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 1-2

ER -

Access to Document